Page 7 - Singular Genomics News Today

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

OMIC earnings call for the period ending December 31, 2021.

The second year of the COVID-19 pandemic saw a wave of global demand for coronavirus tests that finally reached the public markets. Diagnostics companies raised hundreds of millions of, and in some cases over a billion, dollars by pitching Wall Street on their ability to meet that need.

The startup has developed wet lab and artificial intelligence tech to screen small molecules in a less expensive way, giving researchers better odds of uncovering new medicines.

In this timely episode of GEN Live, we’ll discuss all of these topics with genomics veteran and expert in this space—Shawn Baker, PhD. Baker is a genomics startup advisor and consultant. He was one of the first people to join Illumina and has been involved in the genomics space since—for the past 20 years.

Singular Genomics: Elaine Mardis Singular Genomics has added Elaine Mardis to its board of directors. Since 2016, Mardis has served as co-executive director of the Institute of Genomic Medicine at Nationwide Children's Hospital, and holds the Steve and Cindy Rasmussen endowed chair in genomic…

/PRNewswire/ -- GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology,...

HONG KONG, Oct 8, 2021 - (ACN Newswire) - ForQaly Medical (hereinafter referred to as "ForQaly"), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing

Business Scoop provides news and views on Business and Markets from New Zealand

The Biotech Growth Trust Plc - Annual Financial Report PR Newswire London, June 4 LONDON STOCK EXCHANGE ANNOUNCEMENT The Biotech Growth Trust PLC (the "Company") Audited